BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2006
View Archived Issues
sanofi-aventis reviews Q4 fortunes
Read More
Preclinical studies evaluate the activity of PPP in multiple myeloma
Read More
Structure analysis reveals binding of JAK2 and JAK inhibitor
Read More
Antiplatelet activity of MRS-2500 observed ex vivo and in vivo
Read More
Patupilone safe, well tolerated in patients with advanced solid tumors
Read More
Medivir acquires Cathepsin S inhibitor project rights from Peptimmune
Read More
New phase I/II study assesses sublingual vaccines with MPL adjuvant for allergy
Read More
Takeda granted rights for Hematide in Japan
Read More
Immtech licenses aminoquinoline drugs from Tulane University
Read More
Vaccinex enters antibody collaboration with Schering AG
Read More
Panvac-VF phase III study completes enrollment
Read More
QR-435 demonstrates antiviral activity against ocular and genital herpes
Read More
Schering AG exercises option for gadofluorine derivative in Epix collaboration
Read More
Cangene awarded funding to develop PEG-GM-CSF for acute radiation syndrome
Read More
Amgen and Biovitrum expand type 2 diabetes and metabolic disease agreement
Read More
Replidyne and Forest enter U.S. agreement for faropenem medoxomil
Read More
Garenoxacin NDA accepted for review
Read More
NCI to study CTCE-9908 for primary effusion lymphoma
Read More
Fast track designation for tesmilifene for advanced breast cancer
Read More
Nalbuphine ER reduces pain intensity in dose-dependent manner
Read More
FDA warns on risks of aprotinin
Read More
DEBIO-025 well tolerated in HIV-1 infected subjects
Read More
MK-0518 active, well tolerated in resistant HIV-1 infection
Read More
TNX-355 targets HIV in a tropism-independent manner
Read More
New N-type calcium channel blockers emerge from Ajinomoto
Read More
Aricept sNDA accepted for review
Read More
AstraZeneca withdraws Exanta
Read More
Novel therapeutics for neurological disorders reported in recent patent literature
Read More
Recent patents impart novel agents for respiratory disorders
Read More
Recent Ono patent reports new coagulation factor Xa inhibitors
Read More
